Hepatic dysfunction in patients receiving intravenous lipid emulsions.

This review addresses recent developments in the field of intravenous lipid emulsions, including the problem of intestinal failure associated liver disease that can occur with the use of intravenous lipid emulsions in children and adults, and newer intravenous lipid emulsions that may minimize and reverse intestinal failure associated liver disease.